TC BioPharm (Holdings) plc
TCBPDelisted Aug 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001872812
TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in TC BioPharm (Holdings) plc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
TCBP is no longer listed, and 13F filings after Q3 2023 list far fewer holders. See Q3 2023
- Institutional holders
- 1
- −11 vs. Q4 2024
- Shares held
- 173
- −54.7K (−99.7%) vs. Q4 2024
- Total value
- $34
- −$34.8K (−99.9%) vs. Q4 2024
- New holders
- 0
- 0 more added
- Sold out
- 11
- 1 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $34 |
| Q1 2025 | 1 | $34 |
| Q4 2024 | 12 | $34.8K |
| Q3 2024 | 8 | $48.9K |
| Q2 2024 | 8 | $77.0K |
| Q1 2024 | 5 | $42.6K |
| Q4 2023 | 4 | $243.8K |
| Q3 2023 | 12 | $179.6K |
| Q2 2023 | 6 | $380.1K |
| Q1 2023 | 4 | $207.3K |
| Q4 2022 | 2 | $323.8K |
| Q3 2022 | 5 | $141.0K |
| Q2 2022 | 5 | $166.0K |
| Q1 2022 | 8 | $399.0K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding TC BioPharm (Holdings) plc; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rhumbline Advisers | 173 | $34 | 0.00% | −991−85.1% | Reduced |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −15,553−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,042−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −14,316−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −4,127−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1,679−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −1,225−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −236−100.0% | Sold out |
| New England Capital Financial Advisors LLC | 0 | $0 | 0.00% | −201−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −30−100.0% | Sold out |